- Advanced search
- Immuno Portal
- Malaria Portal
Synonyms: Seroquel® | ZM-204636
quetiapine is an approved drug (FDA (1997))
Compound class: Synthetic organic
Comment: Quetiapine displays affinity for numerous receptors from the dopamine, serotonin and adrenergic families, in addition to the histamine H1 receptor. The anti-psychotic properties of the drug are believed to result from its antagonism of dopamine D2 and 5-HT2A receptors.
Marketed formulations may contain quetiapine fumarate (PubChem CID 5281025) or quetiapine hemifumarate (PubChem CID 73013330).
Ligand Activity Visualisation Charts
These are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts.✖
View more information in the IUPHAR Pharmacology Education Project: quetiapine
|No information available.
|Summary of Clinical Use
|Used in the treatment of schizophrenia, bipolar I disorder (acute treatment of manic or depressive episodes), and major depressive disorder.
|Mechanism Of Action and Pharmacodynamic Effects
|Antagonism of D2 receptors in the mesolimbic pathway relieves the positive symptoms of schizophrenia, while antagonism of 5HT2A receptors in the frontal cortex relieves negative symptoms.
For extended ADME data see the following:
Electronic Medicines Compendium (eMC)